BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32427887)

  • 1. Tau affects P53 function and cell fate during the DNA damage response.
    Sola M; Magrin C; Pedrioli G; Pinton S; Salvadè A; Papin S; Paganetti P
    Commun Biol; 2020 May; 3(1):245. PubMed ID: 32427887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein binds to the P53 E3 ubiquitin ligase MDM2.
    Sola M; Rendon-Angel A; Rojo Martinez V; Sgrignani J; Magrin C; Piovesana E; Cavalli A; Paganetti P; Papin S
    Sci Rep; 2023 Jun; 13(1):10208. PubMed ID: 37353565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of MDM2 Stability After DNA Damage.
    Li J; Kurokawa M
    J Cell Physiol; 2015 Oct; 230(10):2318-27. PubMed ID: 25808808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P301L tau mutation leads to alterations of cell cycle, DNA damage response and apoptosis: Evidence for a role of tau in cancer.
    Cimini S; Giaccone G; Tagliavini F; Costantino M; Perego P; Rossi G
    Biochem Pharmacol; 2022 Jun; 200():115043. PubMed ID: 35436464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FATS is an E2-independent ubiquitin ligase that stabilizes p53 and promotes its activation in response to DNA damage.
    Yan S; Qiu L; Ma K; Zhang X; Zhao Y; Zhang J; Li X; Hao X; Li Z
    Oncogene; 2014 Nov; 33(47):5424-33. PubMed ID: 24240685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
    Swaroop M; Sun Y
    Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors.
    Wang HH; Li HL; Liu R; Zhang Y; Liao K; Wang Q; Wang JZ; Liu SJ
    J Alzheimers Dis; 2010; 21(1):167-79. PubMed ID: 20413892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities.
    Abuetabh Y; Wu HH; Chai C; Al Yousef H; Persad S; Sergi CM; Leng R
    Exp Mol Med; 2022 Oct; 54(10):1658-1669. PubMed ID: 36207426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Fate Regulation upon DNA Damage: p53 Serine 46 Kinases Pave the Cell Death Road.
    Liebl MC; Hofmann TG
    Bioessays; 2019 Dec; 41(12):e1900127. PubMed ID: 31621101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair.
    Alt JR; Bouska A; Fernandez MR; Cerny RL; Xiao H; Eischen CM
    J Biol Chem; 2005 May; 280(19):18771-81. PubMed ID: 15734743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
    Buschmann T; Fuchs SY; Lee CG; Pan ZQ; Ronai Z
    Cell; 2000 Jun; 101(7):753-62. PubMed ID: 10892746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP11 regulates p53 stability by deubiquitinating p53.
    Ke JY; Dai CJ; Wu WL; Gao JH; Xia AJ; Liu GP; Lv KS; Wu CL
    J Zhejiang Univ Sci B; 2014 Dec; 15(12):1032-8. PubMed ID: 25471832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologically Increasing Mdm2 Inhibits DNA Repair and Cooperates with Genotoxic Agents to Kill p53-Inactivated Ovarian Cancer Cells.
    Carrillo AM; Hicks M; Khabele D; Eischen CM
    Mol Cancer Res; 2015 Aug; 13(8):1197-205. PubMed ID: 25964101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-16 feedback loop with p53 and Wip1 can regulate cell fate determination between apoptosis and senescence in DNA damage response.
    Issler MVC; Mombach JCM
    PLoS One; 2017; 12(10):e0185794. PubMed ID: 28968438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell death machinery governed by the p53 tumor suppressor in response to DNA damage.
    Yoshida K; Miki Y
    Cancer Sci; 2010 Apr; 101(4):831-5. PubMed ID: 20132225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 prevents neurodegeneration by regulating synaptic genes.
    Merlo P; Frost B; Peng S; Yang YJ; Park PJ; Feany M
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):18055-60. PubMed ID: 25453105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
    Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
    Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.